and that the cleaved bHLH-zip domain is present in nuclear extracts (Theopold et al., 1996) . dSREBP was expressed in all body regions of the fly and at all stages biosynthetic pathway, which allows them to make a vari-SREBP cleavage-activating protein (dSCAP), and the ety of isoprenoids, but they lack the enzymes necessary two proteases that process SREBP at sites 1 and 2 to to convert farnesyl pyrophosphate to squalene and sterelease the nuclear fragment. In cultured Drosophila rols. Insects require sterols for growth, but they obtain S2 cells, dSREBP is processed at sites 1 and 2, and these sterols from their diet (Clark and Bloch, 1959). the liberated fragment increases mRNAs encoding enSince insects do not synthesize sterols, it seems unlikely zymes of fatty acid biosynthesis, but not sterol or isothat sterols are the end products that regulate dSREBP prenoid biosynthesis. Processing requires dSCAP, but cleavage in Drosophila cells. is not inhibited by sterols as in mammals. Instead, The present studies were designed to determine dSREBP processing is blocked by palmitic acid. These whether dSREBP cleavage in insect cells is carried out findings suggest that the ancestral SREBP pathway by the same type of proteolytic mechanism that is used functions to maintain membrane integrity rather than by mammalian cells and to determine whether this cleavto control cholesterol homeostasis.
We began our studies by searching Drosophila DNA sequence databases for genes encoding proteins rethereby providing a mechanism for the feedback regulation of lipid synthesis and membrane lipid composition lated to mammalian SREBPs and to the three proteins known to be necessary for SREBP processing. Verte-(Brown and Goldstein, 1997). Theopold et al. (1996) fortuitously isolated a Drosophbrate organisms have genes encoding two isoforms of SREBP, designated SREBP-1 and SREBP-2. The ila melanogaster cDNA encoding an apparent ortholog to mammalian SREBPs. Like the mammalian proteins, SREBP-1 gene produces two transcripts, designated SREBP-1a and SREBP-1c, that encode proteins with Drosophila SREBP contains an NH 2 -terminal transcription factor domain of the basic-helix-loop-helix-leucine different NH 2 -terminal sequences owing to the use of alternate promoters producing alternate first exons zipper (bHLH-zip) family, followed in order by a putative membrane attachment domain with two transmembrane (Brown and Goldstein, 1997). Although the target genes for these transcription factors overlap, SREBP-2 is relahelices and by a long COOH-terminal extension. Using antibodies raised against the bHLH-zip domain of hutively more selective for genes in the pathway of sterol synthesis, whereas the SREBP-1 isoforms are more seman SREBP-1, these investigators showed that the fulllength Drosophila SREBP is bound to cell membranes lective for production of unsaturated fatty acids (Horton et al., 1998) . domain of dSREBP closely resembles that of human dSREBP has two hydrophobic sequences corresponding to the two transmembrane regions of the mammalian SREBP-1a (82% identity) and human SREBP-2 (66% identity). Importantly, dSREBP contains the unique tyroSREBPs, designated TM1 and TM2. The COOH-terminal sequences of the three proteins are also similar. Of sine residue that was shown to permit SREBPs to bind to nonpalindromic target sequences (Kim et al., 1995) .
note, dSREBP has a relatively long acidic NH 2 -terminal Figure 1D , dS2P has corresponding HEMGH and FDG cessed constitutively, and the cells overaccumulate massive amounts of cholesterol. Tyr-382 in dSCAP corsequences at the appropriate positions. dS2P also shares a cysteine-rich region (ten cysteines), which is responds to Tyr-298 in mammalian SCAP, but the position corresponding to Asp-443 is occupied by an asparaluminally disposed in hS2P (Zelenski et al., 1999) . Figure 3A , treatment with dSREBP dsRNA caused the disappearance of the precursor and nuclear forms of dSREBP as determined by immunoblotting of the appropriate extracts. Treatment with a control dsRNA directed against a control mammalian mRNA (CYP7A1) had no effect on precursor or nuclear dSREBP.
We performed a series of Northern blots to measure changes in mRNA levels for genes that are potential targets of dSREBP in the cells treated with dSREBP dsRNA ( Figure 3B ). As expected, the mRNA for dSREBP On day 0, cells were treated with the indicated dsRNA as described in the legend to Figure 3A were harvested, and membrane and nuclear extract fractions were (A and B) After incubation for 4 hr, cells were harvested, and memprepared as described in Experimental Procedures. Aliquots of probrane and nuclear extract fractions were prepared as described in tein (2.5 g/lane of membrane fraction; 15 g/lane of nuclear extract) Experimental Procedures. Aliquots of protein (2.5 g) were subwere subjected to SDS-PAGE and immunoblot analysis with 50 ng/ jected to SDS-PAGE and immunoblot analysis with 2 g/ml monoml of monoclonal anti-HSV. The filters were exposed to film for either clonal anti-dSREBP (IgG-3B2). The filters were exposed to film for 30 s (A) or 1 min (B). either 10 s (A) or 1 min (B). enter the nucleus. Next, we substituted phenylalanineleucine for an asparagine-proline sequence at position the same site. As shown in Figure 5A Supplemental Table In experiments not shown, we found no additive effect S1 at http://www.developmentalcell.com/cgi/content/ when palmitate or other fatty acids were added to Drofull/2/2/229/DC1). None of them had a significant effect.
sophila cells in combination with sterols. Whether arachidonate in mammalian cells acts by the same mechaDiscussion nism as palmitate in Drosophila cells remains to be determined. The current data establish the following points regarding
In an evolutionary sense, the current data suggest the SREBP pathway in Drosophila: (1) the Drosophila that the original function of the SREBP pathway may genome contains one SREBP gene whose product rehave been to maintain the integrity of the cell membrane sembles mammalian SREBP-1a and SREBP-2; (2) the by adjusting fatty acid synthesis in response to an exDrosophila genome encodes orthologs of mammalian cess or deficiency of palmitic acid or a lipid derived SCAP, S1P, and S2P; (3) dSREBP is processed at site from palmitic acid. During evolution, the single ancestral 1 and site 2 in a process that requires dSCAP, thereby SREBP gene became duplicated in the lineage leading generating an NH 2 -terminal nuclear fragment; (4) nuclear to vertebrates, and the resulting mammalian SREBP prodSREBP enhances transcription of genes encoding enteins acquired additional roles in regulating cholesterol zymes of fatty acid biosynthesis, but not cholesterol or homeostasis and in mediating increased lipid synthesis isoprenoid biosynthesis; and ( . Cells were incubated for 3 hr followed by the direct addition D. Hultmark, Stockholm University, Stockholm, Sweden; previously of ALLN (3 l into 3 ml of medium) to achieve a final concentration referred to as HLH106; Theopold et al., 1996) using primers 5Ј-of 25 g/ml. One hour later the cells were harvested by scraping GAAGATATCGATGACACGACACTGATGAACTTAATAG-3Ј and 5Ј-into the medium, and the cell suspension from duplicate dishes was TTCATCTCTAGACTATCCTAAGCCTTCACGCTGCCAA-3Ј, followed combined. Cells were homogenized and fractionated as described by restriction digestion with BspDI and XbaI to cleave sites at the previously to yield membrane and nuclear extract fractions (Sakai ends of each primer (underlined); and (3) a 179 bp fragment including et al., 1996). a start codon and two copies of the HSV epitope tag generated by PCR from another HSV-tagged expression plasmid using primers Transfection of S2 Cells 5Ј-GATGCAGAATTCAGCCATGCAGCCTGAACTCGCTCCA-3Ј and Cells were set up on day 0 in medium A at a density of 1 ϫ 10 6 cells 5Ј-CGTGTCATCGATATCTTCCGGATCCTCTGG-3Ј, followed by reper 60 mm dish. On day 1, the cells were transfected with a calcium striction digestion with EcoRI and BspDI to cleave sites at the ends phosphate transfection kit (Invitrogen) in medium A according to the of each primer (underlined).
manufacturer's instructions. Cells were incubated with the plasmid pAc-HSV-dSREBP(1-451) encodes the NH 2 -terminal cytosolic do-DNA/calcium phosphate precipitate for either 8 or 16 hr, after which main of dSREBP (amino acids 1-451) with an NH 2 -terminal HSV the cells were washed twice with medium A without serum and refed epitope tag under control of the Drosophila actin 5C promoter. This with medium C as described in the figure legends. plasmid was constructed in the same manner as pAc-HSV-dSREBP, except that the 3.3 kb dSREBP fragment was replaced with a 1.4 kb fragment including codons 2-451 of dSREBP followed by a stop SDS-PAGE and Immunoblot Analysis codon. This fragment was generated by PCR from the dSREBP Protein concentrations in membrane and nuclear extract fractions cDNA plasmid described above using primers 5Ј-GAAGATATCGAT were measured using a BCA kit (Pierce). Prior to SDS-PAGE, the GACACGACACTGATGAACTTAATAG-3Ј and 5Ј-TTCTAGTCTAGAT membrane and nuclear extract fractions were mixed with 0. mouse IgG using the SuperSignal CL-HRP substrate system (Pierce) as previously described (Sakai et al., 1996) . Gels were calibrated with broad range prestained molecular weight markers (Bio-Rad).
Site-Directed Mutagenesis
Plasmids pAc-HSV-dSREBP(R 486 → A) and pAc-HSV-dSREBP(N 462 P → Filters were exposed to Kodak X-Omat Blue XB-1 film (NEN Life Science Products) at room temperature for the indicated time. FL) were created by site-directed mutagenesis of pAc-HSV-dSREBP
